Beyond the midbrain atrophy: wide spectrum of structural MRI finding in cases of pathologically proven progressive supranuclear palsy

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Neuroradiology

• Publication date

  2017-04-06

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00234-017-1812-4PMID 28386688
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Improved Automatic Morphology-Based Classification of Parkinson’s Disease and Progressive Supranuclear Palsy

  2018cited by this paper
• Clinical and imaging findings of progressive supranuclear palsy with predominant cerebellar ataxia

  2016cited by this paper
• Volume of Interest Analysis of Spatially Normalized PRESTO Imaging to Differentiate between Parkinson Disease and Atypical Parkinsonian Syndrome

  2016cited by this paper
• Features of Patients With Nonfluent/Agrammatic Primary Progressive Aphasia With Underlying Progressive Supranuclear Palsy Pathology or Corticobasal Degeneration.

  2016cited by this paper
• Comparison of regional brain atrophy and cognitive impairment between pure akinesia with gait freezing and Richardson's syndrome

  2015cited by this paper
• Midbrain-to-pons ratio in autopsy-confirmed progressive supranuclear palsy: replication in an independent cohort

  2015cited by this paper
• Structural and functional imaging in parkinsonian syndromes.

  2014cited by this paper
• Imaging spectrum of sporadic cerebral amyloid angiopathy: multifaceted features of a single pathological condition

  2014cited by this paper
• The feasibility of white matter volume reduction analysis using SPM8 plus DARTEL for the diagnosis of patients with clinically diagnosed corticobasal syndrome and Richardson’s syndrome

  2014cited by this paper
• Clinical outcomes of two main variants of progressive supranuclear palsy and multiple system atrophy: a prospective natural history study

  2014cited by this paper
• Diffusion tensor imaging comparison of progressive supranuclear palsy and corticobasal syndromes.

  2014cited by this paper
• The midbrain to pons ratio

  2013cited by this paper
• Gray matter atrophy in progressive supranuclear palsy: meta-analysis of voxel-based morphometry studies

  2013cited by this paper
• Midbrain atrophy is not a biomarker of progressive supranuclear palsy pathology

  2013cited by this paper
• Voxelwise meta-analysis of white matter abnormalities in progressive supranuclear palsy

  2013cited by this paper
• The midbrain to pons ratio: A simple and specific MRI sign of progressive supranuclear palsy

  2013cited by this paper
• EFNS task force: the use of neuroimaging in the diagnosis of dementia

  2012cited by this paper
• Conventional magnetic resonance imaging in confirmed progressive supranuclear palsy and multiple system atrophy

  2012cited by this paper
• "Hot cross bun" sign in multiple system atrophy with predominant cerebellar ataxia: a comparison between proton density-weighted imaging and T2-weighted imaging.

  2012cited by this paper
• Neuroanatomical correlates of the progressive supranuclear palsy corticobasal syndrome hybrid

  2012cited by this paper
• A serial MRI study in a patient with progressive supranuclear palsy with cerebellar ataxia.

  2012cited by this paper
• Individual voxel‐based subtype prediction can differentiate progressive supranuclear palsy from idiopathic parkinson syndrome and healthy controls

  2011cited by this paper
• MRI measurements of brainstem structures in patients with Richardson's syndrome, progressive supranuclear palsy‐parkinsonism, and Parkinson's disease

  2011cited by this paper
• MRI measurements predict PSP in unclassifiable parkinsonisms

  2011cited by this paper
• Accuracy of magnetic resonance parkinsonism index for differentiation of progressive supranuclear palsy from probable or possible Parkinson disease

  2011cited by this paper
• Magnetic resonance imaging in progressive supranuclear palsy

  2011cited by this paper
• The in vivo distribution of brain tissue loss in Richardson’s syndrome and PSP‐parkinsonism: a VBM‐DARTEL study

  2010cited by this paper
• Usefulness of 3D-PRESTO imaging in evaluating putaminal abnormality in parkinsonian variant of multiple system atrophy

  2010cited by this paper
• Utility of susceptibility-weighted MRI in differentiating Parkinson’s disease and atypical parkinsonism

  2010cited by this paper
• Imaging-Pathologic Correlation in Corticobasal Degeneration

  2009cited by this paper
• MR imaging index for differentiation of progressive supranuclear palsy from Parkinson disease and the Parkinson variant of multiple system atrophy.

  2008cited by this paper
• Clinical and neuropathologic features of progressive supranuclear palsy with severe pallido-nigro-luysial degeneration and axonal dystrophy.

  2008cited by this paper
• Voxel-based morphometry in autopsy proven PSP and CBD.

  2008cited by this paper
• Progressive Supranuclear Palsy: Pathology and Genetics

  2007cited by this paper
• Pathological tau burden and distribution distinguishes progressive supranuclear palsy-parkinsonism from Richardson's syndrome.

  2007cited by this paper
• Pure akinesia with gait freezing: A third clinical phenotype of progressive supranuclear palsy

  2007cited by this paper
• Imaging of corticobasal degeneration syndrome

  2007cited by this paper
• Clinicopathological and imaging correlates of progressive aphasia and apraxia of speech.

  2006cited by this paper
• Unexpected abundance of pathological tau in progressive supranuclear palsy white matter

  2006cited by this paper
• Regional brain volumes distinguish PSP, MSA‐P, and PD: MRI‐based clinico‐radiological correlations

  2006cited by this paper
• Atypical progressive supranuclear palsy underlying progressive apraxia of speech and nonfluent aphasia

  2005cited by this paper
• New and reliable MRI diagnosis for progressive supranuclear palsy

  2005cited by this paper
• Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism.

  2005cited by this paper
• Quantitative MRI measurement of superior cerebellar peduncle in progressive supranuclear palsy

  2005cited by this paper
• Correlation of midbrain diameter and gait disturbance in patients with idiopathic normal pressure hydrocephalus

  2005cited by this paper
• Increased tau burden in the cortices of progressive supranuclear palsy presenting with corticobasal syndrome

  2005cited by this paper
• Morning glory sign: a particular MR finding in progressive supranuclear palsy.

  2004cited by this paper
• Magnetic resonance imaging-based volumetry differentiates progressive supranuclear palsy from corticobasal degeneration

  2004cited by this paper
• Progressive supranuclear palsy presenting with primary progressive aphasia—Clinicopathological report of an autopsy case

  2003cited by this paper
• Study of the rostral midbrain atrophy in progressive supranuclear palsy.

  2003cited by this paper
• Measurement of the midbrain diameter on routine magnetic resonance imaging: a simple and accurate method of differentiating between Parkinson disease and progressive supranuclear palsy.

  2001cited by this paper
• Epidemiology of progressive supranuclear palsy. ESGAP Consortium. European Study Group on Atypical Parkinsonisms.

  2001cited by this paper
• Epidemiology of progressive supranuclear palsy

  2001cited by this paper
• Frontotemporal lobar degeneration

  1998cited by this paper
• Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome)

  1996cited by this paper
• Progressive supranuclear palsy: MRI and pathological findings

  1996cited by this paper
• Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study.

  1996cited by this paper
• Preliminary NINDS neuropathologic criteria for Steele‐Richardson‐Olszewski syndrome (progressive supranuclear palsy)

  1994cited by this paper
• Pure akinesia: an atypical manifestation of progressive supranuclear palsy.

  1991cited by this paper

• Machine learning and neuroimaging in neurodegenerative disease diagnosis: a systematic review of voxel-based and surface-based morphometry approaches based on PRISMA framework

  2026cites this paper
• Deep Learning‐Based Brainstem Segmentation and Multi‐Class Classification for Parkinsonian Syndrome

  2025cites this paper
• Data-Driven differentiation of idiopathic Normal-Pressure hydrocephalus and progressive supranuclear palsy via automated volumetric analysis

  2025cites this paper
• A Case of Progressive Supranuclear Palsy with Predominant Speech/Language Disorder.

  2025cites this paper
• Comorbid pathologies and their impact on progressive supranuclear palsy: current view.

  2025cites this paper
• Differences in the Regional T1/T2-Weighted Ratio Index Between Healthy Controls and Patients With Progressive Supranuclear Palsy.

  2025cites this paper
• Can Progressive Supranuclear Palsy Be Accurately Identified via MRI with the Use of Visual Rating Scales and Signs?

  2025cites this paper
• Diffusion tensor imaging of sequential neuropathological patterns in progressive supranuclear palsy

  2025cites this paper
• Conventional magnetic resonance imaging key features for distinguishing pathologically confirmed corticobasal degeneration from its mimics: a retrospective analysis of the J-VAC study

  2024cites this paper
• MRI classification of progressive supranuclear palsy, Parkinson disease and controls using deep learning and machine learning algorithms for the identification of regions and tracts of interest as potential biomarkers

  2024cites this paper
• Simple biomarkers to distinguish Parkinson’s disease from its mimics in clinical practice: a comprehensive review and future directions

  2024cites this paper
• Added value of FDG-PET for detection of progressive supranuclear palsy

  2024cites this paper
• Voxel-Based Morphometry of Progressive Supranuclear Palsy Using a 3D Fast Low-angle Shot Localizer Image: A Comparison with Magnetization-Prepared Rapid Gradient Echo

  2024cites this paper
• Brain MRI in Progressive Supranuclear Palsy with Richardson's Syndrome and Variant Phenotypes

  2023cites this paper
• Analysis of Genetic and MRI Changes, Blood Markers, and Risk Factors in a Twin Pair Discordant of Progressive Supranuclear Palsy

  2023cites this paper
• Asymmetric Cerebral Peduncle Atrophy: A Simple Diagnostic Clue for Distinguishing Frontotemporal Lobar Degeneration from Alzheimer’s Disease

  2023cites this paper
• High sensitivity of asymmetric 18F-THK5351 PET abnormality in patients with corticobasal syndrome

  2023cites this paper
• Temporal Progression Patterns of Brain Atrophy in Corticobasal Syndrome and Progressive Supranuclear Palsy Revealed by Subtype and Stage Inference (SuStaIn)

  2022cites this paper
• Clinicoradiological Features in Progressive Supranuclear Palsy Comorbid with Argyrophilic Grains

  2022cites this paper
• Is MRPI 2.0 More Useful than MRPI and M/P Ratio in Differential Diagnosis of PSP-P with Other Atypical Parkinsonisms?

  2022cites this paper
• Rapidly Progressive Corticobasal Degeneration Mimicking Brainstem Encephalitis

  2022influential citation
• Parkinsonian Dementias

  2021cites this paper
• A novel diagnostic marker for progressive supranuclear palsy targeting atrophy of the subthalamic nucleus.

  2021cites this paper
• “Parkinson’s disease” on the way to progressive supranuclear palsy: a review on PSP-parkinsonism

  2021cites this paper
• Comparative morphometric evaluation of the brainstem in neurodegenerative diseases with healthy individuals using magnetic resonance imaging

  2021cites this paper
• Neuroimaging Advances in Parkinson's Disease and Atypical Parkinsonian Syndromes

  2020cites this paper
• Voxel-based morphometry focusing on medial temporal lobe structures has a limited capability to detect amyloid β, an Alzheimer’s disease pathology

  2020cites this paper
• Discriminative pattern of reduced cerebral blood flow in Parkinson’s disease and Parkinsonism-Plus syndrome: an ASL-MRI study

  2020cites this paper
• MRT bei neurodegenerativen Erkrankungen

  2020cites this paper
• Combined Use of 123i-fp-cit Spect and 123i-mibg Scintigraphy for Differentiation of Progressive Supranuclear Palsy Subtypes and Parkinson's Disease

  2020cites this paper
• Methods and utility of quantitative brainstem measurements in progressive supranuclear palsy versus Parkinson's disease in a routine clinical setting

  2020cites this paper
• Increased Signal in the Superior Cerebellar Peduncle of Patients with Progressive Supranuclear Palsy

  2019cites this paper
• MRT bei neurodegenerativen Erkrankungen

  2019cites this paper
• Characteristic asymmetric atrophy in a patient with pathologically confirmed progressive supranuclear palsy

  2019cites this paper
• Midbrain, Pons, and Medulla: Anatomy and Syndromes.

  2019cites this paper
• Increased prefrontal cortex interleukin-2 protein levels and shift in the peripheral T cell population in progressive supranuclear palsy patients

  2019cites this paper
• Combination of midbrain-to-pontine ratio and cardiac MIBG scintigraphy to differentiate Parkinson's disease from multiple system atrophy and progressive supranuclear palsy

  2019cites this paper
• The Progressive Supranuclear Palsy: Past and Present Aspects

  2019cites this paper
• Diagnostic accuracy of MRI parameters in pure akinesia with gait freezing

  2019cites this paper
• Multifaceted structural magnetic resonance imaging findings in demented patients with pathologically confirmed TDP-43 proteinopathy

  2019cites this paper
• Improved Automatic Morphology-Based Classification of Parkinson’s Disease and Progressive Supranuclear Palsy

  2018cites this paper
• Progressive supranuclear palsy responding to intravenous thiamine: superimposed Wernicke’s encephalopathy?

  2018cites this paper
• „Big Data“ und künstliche Intelligenz zur Diagnoseunterstützung bei atypischer Demenz

  2018cites this paper
• 2017/2018

  2017cites this paper
• MRI Diagnosis in Other Dementias

  2017cites this paper
• Interprétation des biomarqueurs du liquide céphalorachidien dans la maladie d’Alzheimer et les dégénérescences lobaires fronto-temporales

  2017cites this paper